Muscular Dystrophy Campaign Welcomes Landmark Embryology Act
Main Category: FertilityArticle Date: 18 Nov 2008 - 8:00 PDT
| Patient / Public: | ![]() |
4 (2 votes) |
| Health Professional: | ![]() |
|
| Article Opinions: | 0 posts |
Commenting on the new Human Fertilisation and Embryology Act, Director of Policy and Campaigns, Robert Meadowcroft, said:
"The Muscular Dystrophy Campaign wholeheartedly welcomes the passing into law of the Human Fertilisation and Embryology Act. The new legislation creates the framework in which vital progress can be made into research of devastating and life-limiting conditions such as muscular dystrophy.
"This is a landmark moment in the lives for our families living with muscle disease, many of whom worked with us and played a key role in ensuring that the Bill was not held back. We were delighted with the enormous amount of support shown by our families, key Parliamentarians and the media in portraying the patient perspective of the impact the legislation.
"The UK will now be able to maintain its position as one of the leading countries in embryo research and this new legislation will ensure that research will be conducted with the highest level of regulation. However the provisions made within the Act are still just a first step in making sure that research can move from the laboratory bench to the patient's bedside."
Muscular Dystrophy Campaign
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





